4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-20-042012
Options or other derivatives
- Chief Financial Officer acquired 3,065,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Wood Gavin Chief Financial Officer | 2020-04-01 | Grant or award · Option to purchase Ordinary Shares | +2,500,000 | 2,500,000 | D | ||
| Wood Gavin Chief Financial Officer | 2020-04-01 | Grant or award · Option to purchase Ordinary Shares | +565,000 | 565,000 | D | ||
Loading xslF345X03/a4.xml…